The challenging evaluation of patients with severe psoriasis for latent tuberculosis: An important indication for IGRA

Open Respiratory Medicine Journal

Volumn 5, Issue 1, 2011, Pages 59-60

  Katsenos, Stamatis ^a   Nikolopoulou, Melita ^a   Tsiouri, Georgia ^a   Bassukas, Ioannis D ^a   Constantopoulos, Stavros H ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Anti tumour necrosis factor therapy; Interferon gamma release assay; Latent tuberculosis infection; Psoriasis; Tuberculin skin test

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; EFALIZUMAB; ETRETIN; INFLIXIMAB;

AGED; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG EFFICACY; DRUG EXPOSURE; FOLLOW UP; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; RISK FACTOR; THORAX RADIOGRAPHY; TREATMENT RESPONSE; TUBERCULIN TEST;

EID: 80053486833     PISSN: None     EISSN: 18743064     Source Type: Journal    
DOI: 10.2174/1874306401105010059     Document Type: Article

References (10)

1. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009. Geneva, Switzerland: World Health Organization 2009. Available at http://www.who.int/tb/publications/globalreport/2009/pdf/reportwithout_annexes.pdf Accessed June 16, 2010.
2. Doherty SD, Van Voorhees A, Lebwohl MG, et al. National Psoriasis Foundation: National psoriasis foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents. J Am Acad Dermatol 2008; 59: 209-17.
3. Lee E, Holzman RS. Evolution and current use of the tuberculin test. Clin Infect Dis 2002; 34: 365-70.
4. Tsiouri G, Gaitanis G, Kiorpelidou D, et al. Tuberculin skin test overestimates tuberculosis hypersensitivity in adult patients with psoriasis. Dermatology 2009; 219: 119-25.
5. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-84.
6. Cellestis Limited QuantiFERON-TB Gold (in-tube method) [package insert][on-line]. Available at http://www.cellestis.com/IRM/content/aust/qtfproducts_tbgoldintubehtml [Accesses on: December 8, 2010].
7. Mazurek GH, Jereb J, Vernon A, et al. IGRA Expert Committee, Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010; 59(RR-5): 1-25.
8. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 2007; 7: 428-38.
9. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 2007; 30: 945-50.
10. Balato N, Ayala F, Gaudiello F. Comparison of tuberculin skin test and interferon-γ assays in patients with moderate to severe psoriasis who are candidates for antitumour necrosis factor-α therapy. Br J Dermatol 2008; 158: 847-8.